Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "alexion pharmaceuticals"

Alexion Appoints John T. Mollen to Board of Directors

Alexion Q1 Profit Up; Lifts Adj. EPS View, Backs Revenue Outlo...

Biopharmaceutical company Alexion Pharmaceuticals, Inc.'s (ALXN: Quote) profit for the first quarter rose to $159.4 million or $0.79 per share from last year's $82.2 million or $0.41 per share. The company said its results included an increase of ..., 4 hours ago

70 images for alexion pharmaceuticals

American Banking News, 34 minutes ago
Irish Independent, 4 days ago
Silicon Republic, 3 weeks ago
4 Traders, 2 weeks ago
Drug Discovery and Development, 1 day ago
American Banking News, 3 weeks ago
Pharma Times, 1 day ago
ABC News 4 Charleston, 1 day ago
Drury, 1 week ago, 1 day ago

Today's Top Health Care Stocks to Watch: AstraZeneca plc, Alexion Pharmaceuticals, Celgene Corporati

Let's take a look at today's top stories in biotech and health care. Keep an eye out for AstraZeneca ( NYSE: AZN ) , Alexion Pharmaceuticals ( NASDAQ: ALXN ) , Celgene Corporation ( NASDAQ: CELG ) and Novartis AG ( NYSE: NVS ) . Alexion ...
 Motley Fool2 hours ago Thursday Sector Laggards: Healthcare, Technology & Communications  Forbes.com1 week ago Health Care Stocks' Vitals Still Look Good  Bloomberg2 days ago

Alexion Pharma raises 2014 profit forecast on strong Soliris sales

April 24 (Reuters) - Alexion Pharmaceuticals Inc reported stronger-than-expected adjusted net earnings due to robust sales of its sole product on the market, Soliris, and it raised its full-year profit forecast for the second time in less than two ...
 CNBC3 hours ago UPDATE 1-Alexion Pharma raises 2014 profit forecast again  Reuters UK1 hour ago

Alexion Pharmaceuticals Inc. CEO Racks Up $30 Million Salary In 2013

The CEO of Alexion, the Cheshire-based pharmaceutical company that makes the most expensive drug in the world, received $30.15 million in compensation last year, according to a federal filing Wednesday. Alexion, which developed a biologic drug from ...
 BioSpace59 minutes ago Alexion CEO Received $30M in Compensation in 2013  Insurance News Net16 hours ago
American Banking News

Alexion Pharmaceuticals Raises Earnings Guidance

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) said it now expects 2014 earnings of $4.38 to $4.48 per share, excluding a one-time benefit of $0.37 per share, and continues to expect revenue of $2.15 billion to $2.17 billion. The company's previous ...
 Individual.com4 hours ago Alexion Pharmaceuticals, Inc. (ALXN) Updates FY14 Earnings Guidance  American Banking News1 hour ago
American Banking News

Alexion Pharmaceuticals beats by $0.27, beats on revenue

Alexion Pharmaceuticals ( ALXN ): Q1 EPS of $1.53 beats by $0.27 . Revenue of $566.6M (+67.2% Y/Y) beats by $6.38M . Press Release Post
 Seeking Alpha5 hours ago Alexion Pharmaceuticals (ALXN) Announces Quarterly Earnings, Beats Estimates By $0.27 EPS  American Banking News3 hours ago Alexion Pharmaceuticals (ALXN) to Release Earnings on Thursday  Mideast Time1 day ago Alexion Pharmaceuticals Receives Consensus Recommendation of Buy from Analysts (NASDAQ:ALXN)  Zolmax News2 weeks ago

Alexion Pharmaceuticals (ALXN) Trading Near $162.91 Resistance Level

After closing Tuesday at $156.10, Alexion Pharmaceuticals Inc ( ALXN ) presents an attractive opportunity to get a 7.94% return in just 59 days, which is an annualized return of 49.11% (for comparison purposes only). To enter this trade, sell one ...
 TradingCharts.com19 hours ago First Week of June 21st Options Trading For Alexion Pharmaceuticals (ALXN)  Forbes.com1 day ago Alexion Pharmaceuticals (ALXN) Showing Support Near $143.59  TradingCharts.com3 days ago May 30th Options Now Available For Alexion Pharmaceuticals (ALXN)  Forbes.com1 week ago

Shares of Alexion Pharmaceuticals Receive a Boost, Up 4.6%

One of today's notable stocks on the rise is Alexion Pharmaceuticals (NASDAQ:ALXN), up 4.6% to $159.17. The Dow is up 0.4% to 16,516 and the S&P is currently up 0.4%
 Individual.com1 day ago Stock Investors Bid Up Shares of Alexion Pharmaceuticals, Up 3.5%  Individual.com2 weeks ago

Alliance Fiber Optic, Talisman Energy, Gilead Sciences, Biogen Idec and Alexion Pharmaceuticals highlighted …

Zacks Equity Research highlights Alliance Fiber Optic ( AFOP - Free Report ) as the Bull of the Day and Talisman Energy ( TLM - Free Report ) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Gilead Sciences Inc. ( ...
 Yahoo! Finance1 day ago

Earnings Release Schedule -- Research on Coca-Cola Enterprises, Alexion Pharma, DuPont Fabros Technology, and Sigma-Aldrich

/PRNewswire/ -- provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ...
 TickerTech.com1 day ago CIGNA : Appointments, Network Agreements, Earnings Results Schedules, and Legal Claims - Analyst Notes on Alexion, Humana, Eli Lilly, Teva and Cigna  4 Traders1 day ago New Data from Studies, Enrollment in Registry, Upcoming Conferences, and Stock Price Movement - Analyst Notes on Alexion, Boston Scientific, Thermo Fisher Scientific, Valeant, and Jazz Pharmaceuticals  Individual.com2 days ago Sigma Aldrich : Earnings Release Schedule -- Research on Coca-Cola Enterprises, Alexion Pharma, DuPont Fabros Technology, and Sigma-Aldrich  4 Traders1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - alexion pharmaceuticals
Get updated on latest news & your favorite topics right in your inbox!
More     Less